Soma & Carisoprodol Pill Identifier: 350mg & 250mg Tablet Markings, Imprints (SOMA 350, V 2410), and Packaging Verification
Soma & Carisoprodol Pill Identifier: 350mg & 250mg Tablet Markings, Imprints (SOMA 350, V 2410), and Packaging Verification
How to identify authentic Soma and generic carisoprodol tablets, verify round white scored imprints, inspect pharmaceutical blister packs, and detect counterfeit pills.
PHARMACEUTICAL IDENTIFIER
EXECUTIVE CLINICAL SUMMARY
Authentic Carisoprodol (Soma®) is formulated in 250mg and 350mg strengths as round, white or off-white oral tablets. Due to carisoprodol’s high street abuse potential and its frequent inclusion in illicit polysubstance “cocktails,” counterfeit pressed tablets containing lethal synthetic fentanyl or unlicensed sedatives have proliferated across rogue online sources. This clinical identification guide provides visual, dimensional, imprint, and blister packaging verification standards.
01. Visual tablet characteristics: Dimensions, shape, scoring, and debossments
Genuine pharmaceutical carisoprodol tablets are round, convex tablets with a smooth, chalk-free matte surface. Authorized manufacturers utilize precise high-tonnage tablet presses that produce sharp edges without crumbly edges or powdery flaking.
| BRAND / GENERIC | STRENGTH | SHAPE & COLOR | DEBOSSED IMPRINTS | PACKAGE FORMAT |
|---|---|---|---|---|
| Brand Soma | 350mg | Round, white tablet | “SOMA” debossed / “350” on reverse | Child-resistant HDPE amber vial |
| Generic (Qualitest / Vintage) | 350mg | Round, white tablet | “V” script logo / “2410” on reverse | Sealed unit-dose blister / bottle |
| Generic (Oxford / Rising) | 350mg | Round, white tablet | “O” logo / “35” on scored reverse | Tamper-sealed pharmaceutical foil |
| Generic (Alvogen) | 350mg | Round, white tablet | “IP 109” debossed / clean bisect | Blister strip packaging |
| Suspect Counterfeit | Various | Chalky, greyish, brittle | Blurry lettering, uneven score line | Loose zip-lock bags / plastic wraps |
02. Blister packaging security features and tamper-evident foil seals
Authentic generic carisoprodol formulations dispensed through licensed pharmacies arrive in medical-grade blister packaging. The backing foil must display crisp printing specifying “Carisoprodol Tablets USP 350mg”, the manufacturer’s trade name, NDC registration code, lot number, and an embossed expiration date on the crimped edge.
03. Physical hardness and dissolution testing under USP monographs
Under United States Pharmacopeia (USP) guidelines, genuine carisoprodol tablets must demonstrate tablet hardness between 6 and 10 kiloponds (kp) and release not less than 80% of active drug in water within 30 minutes. Counterfeit pressed pills often crumble under minimal fingertip pressure or remain completely insoluble due to industrial plaster binders.
04. Proper home storage and protection against moisture degradation
Carisoprodol tablets are susceptible to humidity degradation. Store tablets in their original sealed container with desiccant at controlled room temperature (20°C to 25°C / 68°F to 77°F). Avoid bathroom medicine cabinets where shower steam causes tablet softening and chemical hydrolysis.
05. Counterfeit warning signs and lethal fentanyl adulteration risks
The DEA has repeatedly issued public safety warnings regarding counterfeit “Soma 350” pills pressed with illicit fentanyl or designer benzodiazepines. Extreme danger signs include tablets that vary in thickness within the same blister, uneven score depths, absent lot numbers, or orders shipped without formal pharmacy prescription labeling.
06. Detailed Interneuronal Pharmacology, Spinal Reflex Inhibition & Meprobamate Biotransformation
Carisoprodol (carisoprodol) is a centrally acting skeletal muscle relaxant whose therapeutic relaxation and tranquilizing effects stem from complex interneuronal modulation rather than direct action on skeletal muscle contractile filaments. At the spinal and brainstem levels, carisoprodol interrupts multineuronal reflex arcs within the descending reticular formation and spinal cord gray matter, diminishing sustained hyperactive alpha and gamma motor neuron discharge.
Furthermore, carisoprodol undergoes extensive hepatic biotransformation via cytochrome CYP2C19 into its primary pharmacologically active metabolite, meprobamate. Meprobamate exhibits direct neurochemical properties similar to barbiturates, binding allosterically to the gamma-aminobutyric acid type A (GABA-A) receptor complex at distinct non-benzodiazepine sites. At therapeutic concentrations, it enhances GABA-mediated inhibitory neurotransmission; at elevated concentrations, it can directly open the chloride ion channel in the absence of GABA, inducing profound central sedation and motor ataxia.
| COMPOUND ENTITY | PRIMARY NEUROLOGICAL SITE | MOLECULAR MECHANISM | CLINICAL MANIFESTATION | ELIMINATION HALF-LIFE |
|---|---|---|---|---|
| Parent Carisoprodol | Spinal interneurons, reticular activating system | Interneuronal polysynaptic reflex attenuation | Immediate relief of acute muscle spasm and central stiffness | ~2.0 hours |
| Active Meprobamate | Subcortical limbic circuits, thalamus, GABA-A | Allosteric GABA-A activation (barbiturate-like site) | Anxiolysis, profound central sedation, muscle relaxation | ~10.0 hours |
| CYP2C19 Polymorphism | Hepatic microsomal enzymes | Rate-limiting Phase I oxidative dealkylation | Poor metabolizers retain higher parent drug; rapid metabolizers surge meprobamate | Genotype-dependent |
Because meprobamate possesses a prolonged terminal half-life of 10 hours (compared to 2 hours for parent carisoprodol), repeated daily dosing leads to significant metabolite accumulation. For this reason, clinical guidelines strictly restrict therapy duration to a maximum of 2 to 3 weeks.
07. Hepatic Clearance, Renal Impairment & Beers Criteria Safety
Because Carisoprodol relies heavily on hepatic biotransformation by CYP2C19 into meprobamate followed by renal clearance of polar glucuronides, pharmacokinetic disposition is dramatically altered in organ dysfunction:
| PATIENT POPULATION | PHARMACOKINETIC KINETIC IMPACT | CLINICAL DOSING DIRECTIVE | BEERS CRITERIA GUIDANCE |
|---|---|---|---|
| CYP2C19 Poor Metabolizers | 4-fold elevation in parent carisoprodol exposure | Avoid frequent dosing; monitor for extreme somnolence | Elevated ataxia and psychomotor impairment |
| Hepatic Dysfunction (Child-Pugh A/B) | Impaired clearance of both parent and active meprobamate | Dose reduction or avoid use; prolonged dosing intervals | Risk of hepatic encephalopathy and toxicity |
| Renal Impairment (CrCl < 30 mL/min) | Accumulation of active meprobamate metabolite | Contraindicated or extreme specialist monitoring only | Prolonged sedation and central depression |
| Geriatric Patients (≥ 65 Years) | Pronounced anticholinergic and sedative sensitivity | AVOID: Categorized as Potentially Inappropriate (PIM) | High risk of falls, hip fractures, and confusion |
Under the AGS Beers Criteria®, skeletal muscle relaxants like carisoprodol are strongly advised against in older adults due to poor tolerability, pronounced anticholinergic adverse effects, sedation, and a statistically validated threefold increase in fall-related fractures.
08. Comprehensive Patient Clinical Safety & Dispensing Checklist
Before taking Carisoprodol, patients and prescribers must verify this clinical safety checklist to prevent dangerous sedative synergy and dependence:
PATIENT SAFETY & USE LIMIT CRITERIA
- Strict Duration Limit: Therapy must not exceed 2 to 3 weeks. Long-term use results in physical dependence on meprobamate and difficult discontinuation.
- Zero Alcohol Tolerance: Completely avoid all alcohol and ethanol-containing elixirs. Co-ingestion causes severe psychomotor collapse and respiratory depression.
- The “Holy Trinity” Warning: Never combine carisoprodol with opioids and benzodiazepines. This triple combination carries an extreme risk of fatal overdose.
- Driving & Machinery Abstinence: Do not drive, operate forklifts, or engage in safety-critical tasks while on carisoprodol therapy.
- Seizure & Porphyria History: Contraindicated in patients with acute intermittent porphyria or past meprobamate hypersensitivity.
09. Verified Pharmaceutical Formulations & Prescribing Profiles
Soma 350mg (Carisoprodol)
Centrally acting skeletal muscle relaxant indicated for the acute relief of painful musculoskeletal spasms, strains, and spastic back injuries.
10. Frequently Asked Questions
What does a real 350mg Soma pill look like?
Authentic brand Soma 350mg is a round, white tablet debossed with the word “SOMA” on one side and “350” on the other. Common generics feature markings like “V 2410” or “IP 109”.
What is the “V 2410” pill?
The “V 2410” pill is an authentic, FDA-approved generic carisoprodol 350mg tablet manufactured by Qualitest/Vintage Pharmaceuticals.
Why do counterfeit Soma pills exist?
Because carisoprodol metabolizes into meprobamate and is a controlled substance with street demand, illicit drug cartels press fake pills that often contain deadly fentanyl instead of genuine carisoprodol.
Can authentic carisoprodol tablets be cut in half along the score line?
Yes. Tablets that possess a clean central bisect line can be split using a pharmacy pill cutter to administer half-doses if directed by your prescriber.
What should I do if my tablets arrive loose or have no markings?
Never take unidentifiable or loose unmarked pills. Contact a licensed pharmacist immediately with photos of the medication and report the shipment.
11. Clinical References & Regulatory Sources
- United States Pharmacopeia (USP). Carisoprodol Tablets Official Compendium. Source Database.
- DEA Diversion Control Division. Chemical Analysis of Seized Counterfeit Prescription Sedatives. Source Database.
- FDA CDER. Pill Identification Guide and Consumer Drug Safety Alerts. Source Database.
Consult a Clinical Pharmacy Specialist
Have questions regarding Carisoprodol dosing intervals, CYP enzyme interactions, or physician-guided discontinuation protocols? Connect with our licensed clinical pharmacy team for patient safety guidance.
Related Patient Services & Verified Care
Every prescription order is verified by a licensed pharmacist in strict adherence to FDA BeSafeRx protocols.